Comparison of two electronic screening tests (culturally neutral & culturally customized) for major and minor...

While attempting to test the population for Mild and Major Neurocognitive Disorders (M. - M. N.D.) there are tests in conventional and electronic form which are applied. However, a large proportion of elderly avoids being tested as the process itself causes stress and fatigue. The structure of the tests is often irrelevant to the experiences and life of the elderly as it focuses on the standard arraying of the diagnostic criteria.

A) the introduction of a culturally oriented screening test based on folk tradition. B) exploiting the advantages of technology in an electronic version of this test, in order: To be administered by non-specialist and/or people of the elderly's environment. To be given to people with sensory impairments of vision or hearing - speech.

1. Automation of the delivery and evaluation process in order to avoid the bias effect due to differences between examiners. Use of multimedia and innovative interfaces. 2. Application of the electronic version to a sample of 300 people of both sexes and 60+ years old. The evaluation of the culturally customized test will be done on the following axes: Metric Capacity in detection of Major and Mild ND. For this case, the reference point are normalized screening tests. Evaluation of usability and acceptance by examinees, examiners, caregivers and health professionals using normalized tools and interviews. 3. Comparative study with an electronic state-of-the-art screening test (TAB CAT) for M-MND in a sample of 120 individuals aiming in comparing the tests for ease of use and acceptance by the test subjects.All participants will be from 60 years old and above, having the Greek language as native language, without any limitations on the educational level. Participants will be divided into 3 groups according to their diagnosis (normal, Mild ND, Major ND) Expected Benefits: The potential effectiveness of the innovative screening method for Mild - Major ND is expected to increase the number of elderlies who treated for neurocognitive impairment while reducing examination costs.